NOUS-209
N/A
Report date: 2022/12/31 17:30:04
Base Information
Drug NameNOUS-209
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[7]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNouscom SRL
China Registration ClassN/A
Develop Information
Active CompaniesNational Cancer InstituteNouscom SRL
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A